Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: The rapid outbreak of coronavirus disease 2019 (COVID‐19) has turned into a public health emergency of international concern. Epidemiological research has shown that sex is associated with the severity of COVID‐19, but the underlying mechanism of sex predisposition remains poorly understood. We aim to study the gendered differences in inflammation reaction, and the association with severity and mortality of COVID‐19. Methods: In this retrospective study, we enrolled 548 COVID‐19 inpatients from Tongji Hospital from 26 January to 5 February 2020, and followed up to 3 March 2020. Epidemiological, demographic and clinical features, and inflammatory indexes were collected and compared between males and females. The Cox proportional hazard regression model was applied to identify the gendered effect on mortality of COVID‐19 after adjusting for age, comorbidity, and smoking history. The multiple linear regression method was used to explore the influence of sex on inflammation reaction. Results: Males had higher mortality than females did (22.2% vs 10.4%), with an hazard ratio of 1.923 (95% confidence interval, 1.181‐3.130); elder age and comorbidity were significantly associated with decease of COVID‐19 patients. Excess inflammation reaction was related to severity of COVID‐19. Male patients had greater inflammation reaction, with higher levels of interleukin 10, tumor necrosis factor‐α, lactose dehydrogenase, ferritin, and hyper‐sensitive C‐reactive protein, but a lower lymphocyte count than females adjusted by age and comorbidity. Conclusions: Sex, age, and comorbidity are critical risk factors for mortality of COVID‐19. Excess innate immunity and proinflammation activity, and deficiency in adaptive immunity response promote males, especially elder males, to develop a cytokine storm, causing potential acute respiratory distressed syndrome, multiple organ failure and decease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657 · cited 4×
“Recent research has demonstrated that patients with comorbidities had greater disease severity compared with those without.(19) In this study, considering gender, age, smoking history, and comorbidity, univariable and multivariable analyses to identify risk factors associated with death of all enrolled COVID-19 patien…”
MethodInfluentialCOVID-19: the gendered impacts of the outbreak
Wenham, C., Smith, J., & Morgan, R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30526-2 · Cited by 1,701
Sexual-dimorphism in human immune system aging
Márquez, E. J., Chung, C.-H., Marches, R., Rossi, R. J., Nehar-Belaid, D., Eroglu, A., Mellert, D. J., Kuchel, G. A., Banchereau, J., & Ucar, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14396-9 · Cited by 584 · cited 2×
“Besides, elder patients had immune disorders including age-related defects in T-cell and B-cell function and the excess production of inflammatory cytokines, which could lead to a deficiency in control of viral replication and more prolonged proinflammatory responses and poor outcomes.33 Márquez et al.34 also conclude…”
BackgroundCytokine storm intervention in the early stages of COVID-19 pneumonia
Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., et al. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.002 · Cited by 513 · cited 1×
“Meanwhile, cytokine storm could also result in immunopathogenic damage to tissues and organs.(23,24)”
BackgroundTorcia, M. G., Nencioni, L., Clemente, A. M., Civitelli, L., Celestino, I., Limongi, D., Fadigati, G., Perissi, E., Cozzolino, F., Garaci, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039853 · Cited by 151
Cited by
Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
Cheng, L., Li, H., Li, L., Liu, C., Yan, S., Chen, H., & Li, Y. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23618 · Cited by 387
Haitao, T., Vermunt, J. V., Abeykoon, J., Ghamrawi, R., Gunaratne, M., Jayachandran, M., Narang, K., Parashuram, S., Suvakov, S., & Garovic, V. D. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.024 · Cited by 297
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 258
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202249 · Cited by 177
Bucciarelli, V., Nasi, M., Bianco, F., Seferovic, J., Ivkovic, V., Gallina, S., & Mattioli, A. V. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.09.009 · Cited by 152
Lau, E. S., McNeill, J. N., Paniagua, S. M., Liu, E. E., Wang, J. K., Bassett, I. V., Selvaggi, C. A., Lubitz, S. A., Foulkes, A. S., & Ho, J. E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250774 · Cited by 65
“In an early study of 548 COVID-19 inpatients in China, men had higher levels of hsCRP, ferritin, and IL-10, but lower lymphocyte count compared with women even after adjustment for age and comorbidities [23].”
Background
Metadata
- Authors
- Qin, L., Li, X., Shi, J., Yu, M., Wang, K., Tao, Y., Zhou, Y., Zhou, M., Xu, S., Wu, B., Yang, Z., Zhang, C., Yue, J., Cheng, C., Liu, X., & Xie, M.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-06-19
- Volume
- 92
- Issue
- 11
- Pages
- 2684-2692
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3033606323
- Cited by
- 103
- References
- 7
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.